GLP-1 Agonists Linked to Increased Reporting of Depressed Mood and Suicidal Thoughts
Background
GLP-1 receptor agonists (GLP-1 RAs) like semaglutide and liraglutide are highly effective treatments for type 2 diabetes and obesity, known for their glucose-lowering and weight-loss benefits. However, recent anecdotal reports have raised concerns about potential psychiatric adverse effects, including depressed mood and suicidal thoughts. This study utilized a large global pharmacovigilance database to systematically investigate the association between GLP-1 RAs and these serious mental health outcomes.
Results
The analysis revealed a significantly higher reporting odds ratio (ROR) for both depressed mood and suicidal thoughts with GLP-1 RAs compared to other antidiabetic medications. For depressed mood, the ROR was 1.8 (95% CI: 1.7-1.9, p<0.001), indicating an 80% increased reporting odds. > The most striking finding was a 2.5-fold increased reporting odds for suicidal thoughts among patients using GLP-1 RAs compared to those on other antidiabetic medications (ROR 2.5, 95% CI: 2.3-2.7, p<0.001). This association was consistent across various individual GLP-1 RA compounds, including semaglutide and liraglutide, and persisted after adjusting for potential confounders. Overall, 0.05% of GLP-1 RA reports mentioned suicidal thoughts, compared to 0.02% for other antidiabetics, representing a 150% relative increase in reporting frequency.
Why It Matters
This study highlights a critical safety signal, suggesting that GLP-1 receptor agonists may be associated with an increased risk of depressed mood and suicidal ideation in real-world settings. This finding underscores the importance of careful patient monitoring for psychiatric symptoms during GLP-1 RA treatment. Clinicians should consider screening for a history of mental health conditions before prescribing these medications and counsel patients on potential risks. Further research, including prospective observational studies and potentially randomized controlled trials, is needed to confirm these associations and elucidate underlying mechanisms.